Home
Lynx1 Capital Management, 10% Owner: Cullinan Therapeutics CGEM Buy · Filed 25/10/10
Trade details
- Type
- Insider buy
- Amount
- $2,040,913.28
- Shares · price
- 277,298 sh · $7.36 a share
- Held after
- 8,549,084 sh
- Trade date
- 25/10/10
- Filed
- 25/10/10
- Days to filing
- 0 days
First buy since 2023
- Insiders buying this week
- 2 insiders
- Holding change
- +3.4%
Cullinan Therapeutics trades, last 26 weeks
What else happened in Cullinan Therapeutics around then
Filed or reported within 30 days of the trade day · 25/09/10~25/11/09Lynx1 Capital Management's recent trades
- Lynx1 Capital Management
BuyPassage BIO
BuyPassage BIO
PASG
$206.2K
50,055 sh
$206.2K
Filed 06/29
Traded 06/25
- Lynx1 Capital Management
BuyKorro Bio
BuyKorro Bio
KRRO
$5,512
520 sh
$5,512
Filed 04/02
Traded 03/31
- Lynx1 Capital Management
BuyTScan Therapeutics
BuyTScan Therapeutics
TCRX
$72.1K
80,069 sh
$72.1K
Filed 25/12/23
Traded 25/12/19
- Lynx1 Capital Management
BuyTScan Therapeutics
BuyTScan Therapeutics
TCRX
$68K
75,500 sh
$68K
Filed 25/12/23
Traded 25/12/22
- Lynx1 Capital Management
BuyTScan Therapeutics
BuyTScan Therapeutics
TCRX
$5,609
6,232 sh
$5,609
Filed 25/12/23
Traded 25/12/23
